1. Yan, ZP, Yang, M, Lai, CL. COVID-19 vaccines: A review of the safety and efficacy of current clinical trials. Pharmaceuticals 2021; 14: 406. doi:10.3390/PH14050406
Google Scholar | Crossref | Medline2. Moghadasi, AN, Mirmosayyeb, O, Barzegar, M, Sahraian, MA, Ghajarzadeh, M. The prevalence of COVID-19 infection in patients with multiple sclerosis (MS): a systematic review and meta-analysis. Neurol Sci 2021; 1: 1. doi:10.1007/S10072-021-05373-1
Google Scholar | Crossref3. Möhn, N, Konen, FF, Pul, R, et al. Experience in multiple sclerosis patients with COVID-19 and disease-modifying therapies: A review of 873 published cases. J Clin Med 2020; 9: 4067. doi:10.3390/JCM9124067
Google Scholar | Crossref4. Achiron, A, Dolev, M, Menascu, S, et al. COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021. Mult Scler J 2021; 27: 864–870. doi:10.1177/13524585211003476
Google Scholar | SAGE Journals | ISI5. Friedli, C, Diem, L, Hammer, H, et al. Negative SARS-CoV2-antibodies after positive COVID-19-PCR nasopharyngeal swab in patients treated with anti-CD20 therapies. Ther Adv Neurol Disord 2021; 14: 175628642110166. doi:10.1177/17562864211016641
Google Scholar | SAGE Journals6. Achiron, A, Mandel, M, Dreyer-Alster, S, et al. Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies. Ther Adv Neurol Disord 2021; 14: 17562864211012836. doi:10.1177/17562864211012835
Google Scholar | SAGE Journals | ISI7. Jehi, L, Ji, X, Milinovich, A, et al. Development and validation of a model for individualized prediction of hospitalization risk in 4,536 patients with COVID-19. PLoS One 2020; 15: e0237419. doi:10.1371/JOURNAL.PONE.0237419
Google Scholar | Crossref | Medline8. Gadani, SP, Reyes-Mantilla, M, Jank, L, et al. Discordant humoral and T cell immune responses to SARS-CoV-2 vaccination in people with multiple sclerosis on anti-CD20 therapy. Preprint. medRxiv. 2021. 2021.08.23.21262472. Published 25 August 2021. doi:10.1101/2021.08.23.21262472
Google Scholar | Crossref9. Apostolidis, SA, Kakara, M, Painter, MM, et al. Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy [published online ahead of print, 14 September 2021]. Nat Med. 2021. 10.1038/s41591-021-01507-2. doi:10.1038/s41591-021-01507-2
Google Scholar | Crossref | Medline